AnalystsEdward Nash
Edward Nash's Stock Forecasts

Analyst Ranking
Top 7%
#347 out of 5267 analysts
Average Return
+23.44%
Win Rate
56%54 out of 96
Risk vs Reward
Poor
Good

Edward Nash's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Verona Pharma PLCVRNA
+511.40%$15.44$94.40
2024-06-27 -
2025-06-26
Strong Buy
Verona Pharma PLCVRNA
+357.91%$22.88$104.77
2024-07-22 -
2025-07-09
Strong Buy
Cardiol Therapeutics IncCRDL
+267.80%$0.59$2.17
2023-05-19 -
2024-05-17
Strong Buy
Travere Therapeutics IncTVTX
+195.56%$6.75$19.95
2024-05-07 -
2025-05-06
Strong Buy
Verona Pharma PLCVRNA
+172.91%$38.39$104.77
2024-11-05 -
2025-07-09
Strong Buy

Edward Nash Analyst Color

Get additional color on Edward Nash's coverage of popular stocks

Edward Nash's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Sagimet Biosciences IncSGMT
3Strong Buy$49.00+520.25%Maintains
a day ago
Kiniksa Pharmaceuticals International PLCKNSA
2Strong Buy$64.00+11.07%Maintains
6 days ago
Structure Therapeutics IncGPCR
1Strong Buy$101.00+134.67%Initiates Coverage On
8 days ago
Travere Therapeutics IncTVTX
11Strong Buy$56.00+24.69%Maintains
21 days ago
Cardiol Therapeutics IncCRDL
4Strong Buy$8.00+501.50%Maintains
a month ago
Rani Therapeutics Holdings IncRANI
3Strong Buy$5.00+436.48%Maintains
a month ago
Corcept Therapeutics IncCORT
13Strong Buy$110.00+113.18%Maintains
a month ago
Apogee Therapeutics IncAPGE
2Strong Buy$130.00+55.60%Maintains
a month ago
Pliant Therapeutics IncPLRX
3Hold$3.00+152.10%Maintains
2 months ago
Ventyx Biosciences IncVTYX
8Hold$14.000.00%Downgrades
4 months ago
Veru IncVERU
1Strong Buy$25.00+1,011.11%Initiates Coverage On
5 months ago
Madrigal Pharmaceuticals IncMDGL
10Strong Buy$587.00+13.18%Maintains
6 months ago
Viking Therapeutics IncVKTX
2Strong Buy$107.00+236.90%Maintains
6 months ago
Akero Therapeutics IncAKRO
6Hold$54.00-1.19%Downgrades
7 months ago
Inventiva SaIVA
3Strong Buy$20.00+279.51%Maintains
7 months ago
Celldex Therapeutics IncCLDX
3Strong Buy$62.00+89.20%Maintains
8 months ago
Verona Pharma PLCVRNA
8Hold$107.00+0.08%Downgrades
10 months ago
Morphic Holding IncMORF
2Strong Buy$66.00N/AMaintains
2 years ago
Intercept Pharmaceuticals IncICPT
7Hold$19.00N/ADowngrades
3 years ago
Theratechnologies IncTHTX
4Hold$8.00N/AAssumes
3 years ago
Dice Therapeutics IncDICE
3Hold$48.00N/ADowngrades
3 years ago
Oramed Pharmaceuticals IncORMP
2Hold$2.00N/AMaintains
3 years ago
Amryt Pharma PLCAMYT
2Hold$17.00N/ADowngrades
3 years ago
Galmed Pharmaceuticals LtdGLMD
2Hold$180.00N/ADowngrades
4 years ago
Chemocentryx IncCCXI1
2Hold$52.00N/ADowngrades
4 years ago
Rezolute IncRZLT
1Strong Buy$17.00N/AAssumes
4 years ago
Obseva SaOBSVF
1Strong Buy$12.00N/AInitiates Coverage On
4 years ago
Metacrine IncMTCR
1Hold$1.00N/ADowngrades
5 years ago
Adverum Biotechnologies IncADVM
3Hold$80.00N/AMaintains
7 years ago
Ultragenyx Pharmaceutical IncRARE
2Strong Buy$54.00N/AMaintains
8 years ago
Entasis Therapeutics Holdings IncETTX
1Strong Buy$20.00N/AInitiates Coverage On
8 years ago
Uniqure NvQURE
1Strong Buy$48.00N/AInitiates Coverage On
8 years ago
Abeona Therapeutics IncABEO
1Strong Buy$650.00N/AInitiates Coverage On
8 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.